- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FTC clears Loral acquisition plan
The Federal Trade Commission has given Lockheed Martin the go-aheadto buy Loral on the condition that it take measures to limit thepossibility of antitrust conflicts in the defense industry. TheFTC's concerns had delayed the consummation of the merger,
The Federal Trade Commission has given Lockheed Martin the go-ahead
to buy Loral on the condition that it take measures to limit the
possibility of antitrust conflicts in the defense industry. The
FTC's concerns had delayed the consummation of the merger, which
was announced earlier this year (SCAN 1/17/96).
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
